Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (5) | B (2) | C (4) | D (4) | E (8) | F (1) | G (4) | I (3) | L (3) | N (1) | O (2) | P (2) | R (1) | S (6) | T (7) | U (1) | V (1) | W (2)
Generic Name Common Trade Name(s)sort icon Classification Date Marketed in Canada (yyyy/mm/dd)
Onasemnogene Zolgensma Cellular and gene therapy 2021/02/04
Niraparib Zejula Antineoplastic agent 2020/01/09
Axicabtagene ciloleucel Yescarta Antineoplastic agent 2019/11/27
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Baloxavir marboxil Xofluza Antiviral agent 2020/02/19
Tafamidis Vyndaqel Selective stabilizer of transthyretin - cardiac drug 2020/04/07
Eptinezumab Vyepti Prevention of migraine; calcitonin gene-related peptide binding antibody 2021/01/11
Cabotegravir Vocabria Antiretroviral agent 2020/03/19
Dacomitinib Vizimpro Tyrosine kinase inhibitor 2019/04/22
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Abemaciclib Verzenio Protein kinase inhibitor 2019/07/03
Patiromer Veltassa Potassium binder 2020/03/09
Tucatinib Tukysa Antineoplastic agent 2020/10/08
Elexacaftor + tezacaftor + ivacaftor Trikafta Cystic fibrosis transmembrane conductance regulator correctors 2021/06/22
Tibolone Tibella Hormone replacement therapy 2020/07/29
Tepotinib Tepmetko Protein kinase inibitor (antineoplastic agent)
Sumatriptan + naproxen Suvexx Serotonin receptor agonist + NSAID 2020/07/24
Esketamine Spravato Antidepressant 2020/05/20
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Semaglutide Rybelsus Incretin mimetic 2020/04/19
Entrectinib Rozlytrek Antineoplastic agent
Edaravone Radicava Treatment for amyotrophic lateral sclerosis 2019/10/29
Ponesimod Ponvory Sphingosine 1-phosphate receptor modulator 2021/04/28
Alpelisib Piqray Antineoplastic agent 2020/03/11
Teriparatide Osnuvo Bone formation agent 2020/10/27
Sonidegib Odomzo Antineoplastic agent 2020/06/11
Darolutamide Nubeqa Anti-androgen 2020/03/24
Drospirenone + estetrol Nextstellis Oral contraceptive 2021/06/15
Etonogestrel Nexplanon Hormonal contraceptive 2020/08/17
Siponimod Mayzent Immunomodulatory agent 2020/04/24
Voretigene Luxturna Cellular and gene therapy 2020/10/13
Eszopiclone Lunesta Hypnotic 2020/10/20
Lorlatinib Lorbrena Tyrosine kinase inhibitor 2019/04/22
Sodium zirconium cyclosilicate Lokelma Potassium binder 2019/10/17
Cemiplimab Libtayo Antineoplastic agent 2019/05/24
Apomorphine Kynmobi Nonergot-derivative dopamine receptor agonist 2020/06/12
Syndicate content